These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 24360597)

  • 1. Influence of dexmedetomidine therapy on the management of severe alcohol withdrawal syndrome in critically ill patients.
    Frazee EN; Personett HA; Leung JG; Nelson S; Dierkhising RA; Bauer PR
    J Crit Care; 2014 Apr; 29(2):298-302. PubMed ID: 24360597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
    Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV
    Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Early Dexmedetomidine Addition to the Standard of Care for Severe Alcohol Withdrawal in the ICU: A Retrospective Controlled Cohort Study.
    VanderWeide LA; Foster CJ; MacLaren R; Kiser TH; Fish DN; Mueller SW
    J Intensive Care Med; 2016 Mar; 31(3):198-204. PubMed ID: 25326428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Dexmedetomidine-Associated Hemodynamic Instability in Noncardiac Intensive Care Unit Patients.
    Ice CJ; Personett HA; Frazee EN; Dierkhising RA; Kashyap R; Oeckler RA
    Anesth Analg; 2016 Feb; 122(2):462-9. PubMed ID: 26702868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Addition of Dexmedetomidine as an Adjunctive Therapy to Benzodiazepine Use in Alcohol Withdrawal Syndrome: A Literature Review.
    Ferenchak TA
    J Addict Nurs; 2017; 28(4):188-195. PubMed ID: 29200045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Addition of Dexmedetomidine as an Adjunctive Therapy to Benzodiazepine Use in Alcohol Withdrawal Syndrome: A Literature Review.
    Ferenchak TA
    J Addict Nurs; 2017; 28(4):E1-E2. PubMed ID: 29200055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine for Alcohol Withdrawal Syndrome.
    Linn DD; Loeser KC
    Ann Pharmacother; 2015 Dec; 49(12):1336-42. PubMed ID: 26400008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal.
    Mueller SW; Preslaski CR; Kiser TH; Fish DN; Lavelle JC; Malkoski SP; MacLaren R
    Crit Care Med; 2014 May; 42(5):1131-9. PubMed ID: 24351375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propofol for Treatment of Refractory Alcohol Withdrawal Syndrome: A Review of the Literature.
    Brotherton AL; Hamilton EP; Kloss HG; Hammond DA
    Pharmacotherapy; 2016 Apr; 36(4):433-42. PubMed ID: 26893017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged sedation in critically ill children: is dexmedetomidine a safe option for younger age? An off-label experience.
    Sperotto F; Mondardini MC; Vitale F; Daverio M; Campagnano E; Ferrero F; Rossetti E; Vasile B; Dusio MP; Ferrario S; Savron F; Brugnaro L; Amigoni A;
    Minerva Anestesiol; 2019 Feb; 85(2):164-172. PubMed ID: 30394067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review.
    Woods AD; Giometti R; Weeks SM
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):224-52. PubMed ID: 26447017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Symptom-Triggered Benzodiazepine Protocol Utilizing SAS and CIWA-Ar Scoring for the Treatment of Alcohol Withdrawal Syndrome in the Critically Ill.
    Sen S; Grgurich P; Tulolo A; Smith-Freedman A; Lei Y; Gray A; Dargin J
    Ann Pharmacother; 2017 Feb; 51(2):101-110. PubMed ID: 27733668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Propofol Plus Dexmedetomidine in Patients Experiencing Severe Alcohol Withdrawal in the Intensive Care Unit.
    Love K; Zimmermann AE
    J Clin Pharmacol; 2020 Apr; 60(4):439-443. PubMed ID: 31663139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine as Single Continuous Sedative During Noninvasive Ventilation: Typical Usage, Hemodynamic Effects, and Withdrawal.
    Shutes BL; Gee SW; Sargel CL; Fink KA; Tobias JD
    Pediatr Crit Care Med; 2018 Apr; 19(4):287-297. PubMed ID: 29341985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects From Continuous Infusions of Dexmedetomidine and Propofol on Hemodynamic Stability in Critically Ill Adult Patients With Septic Shock.
    Nelson KM; Patel GP; Hammond DA
    J Intensive Care Med; 2020 Sep; 35(9):875-880. PubMed ID: 30260732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Acute Alcohol Withdrawal Syndrome in Critically Ill Patients.
    Dixit D; Endicott J; Burry L; Ramos L; Yeung SY; Devabhakthuni S; Chan C; Tobia A; Bulloch MN
    Pharmacotherapy; 2016 Jul; 36(7):797-822. PubMed ID: 27196747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic Effects of Propofol and Dexmedetomidine in Septic Patients Without Shock.
    Benken S; Madrzyk E; Chen D; Lopez J; Schmelzer D; Sessions Z; Patel G; Hammond D
    Ann Pharmacother; 2020 Jun; 54(6):533-540. PubMed ID: 31849243
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcomes of Patients with Alcohol Withdrawal Syndrome Treated with High-Dose Sedatives and Deferred Intubation.
    Stewart R; Perez R; Musial B; Lukens C; Adjepong YA; Manthous CA
    Ann Am Thorac Soc; 2016 Feb; 13(2):248-52. PubMed ID: 26799430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome.
    Lee JA; Duby JJ; Cocanour CS
    Clin Toxicol (Phila); 2019 Jul; 57(7):624-627. PubMed ID: 30729859
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Adjunctive Dexmedetomidine in the Treatment of Alcohol Withdrawal Compared to Benzodiazepine Symptom-Triggered Therapy in Critically Ill Patients: The EvADE Study.
    Collier TE; Farrell LB; Killian AD; Kataria VK
    J Pharm Pract; 2022 Jun; 35(3):356-362. PubMed ID: 33297835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.